Pricing Log in Create free account

Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY) vs REGENXBIO Inc. (RGNX)

Ceryvyn Therapeutics Ltd. - Unsponsored ADR and REGENXBIO Inc. are both Biotechnology companies. Ceryvyn Therapeutics Ltd. - Unsponsored ADR and REGENXBIO Inc. are of similar size ($524.8M and $508.5M). REGENXBIO Inc. has the higher net margin (−113.9% vs −89,724.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Ceryvyn Therapeutics Ltd. - Unsponsored ADR leads on 7 and REGENXBIO Inc. on 7.

Valuation

Metric CYVNY RGNX Biotechnology median
P/E n/m n/m 10.96
P/S 2.37 3.29 9.52
P/B n/m 3.42 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 759.28 1.69 9.00
Earnings yield (2,375.00%) (41.47%) (32.09%)
Free cash flow yield (84,379.36%) (30.61%) (22.62%)

Profitability

Metric CYVNY RGNX Biotechnology median
Gross margin 0.00% 87.54% 68.51%
Operating margin 0.00% (95.68%) 0.00%
Net margin (89,724.18%) (113.85%) 0.00%
Free cash flow margin 0.00% (100.58%) 0.00%
Return on equity 0.00% (113.24%) (50.12%)
Return on assets 0.00% (35.36%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYVNY RGNX Biotechnology median
Revenue growth (TTM) — (4.59%) 6.78%
EPS growth (last fiscal year) 61.59% 18.08% 29.88%
Revenue growth, 5-year CAGR (15.81%) 1.97% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYVNY RGNX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.22 4.74 4.74
Net debt to EBITDA 0.31 1.58 1.01

Dividend

Metric CYVNY RGNX Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric CYVNY RGNX Biotechnology median
Market cap 524.83m 508.48m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack